Travel grant 2025 Singapore, Delegation to Singapore, 8 Sep
| Reference number | |
| Coordinator | Prolevi Bio AB |
| Funding from Vinnova | SEK 15 000 |
| Project duration | September 2025 - September 2025 |
| Status | Ongoing |
| Venture | Global cooperation 2025 |
Important results from the project
Singapore ecosystem is well established and supported by massive RnD funding, tax incentives, High net individuals and family office investments thats equally attractive as venture capital.
Expected long term effects
Financing and collaborations along with impact on Women´s Health with first treatment for Hypothyroid patients that do not respond to current treatment.
Approach and implementation
It went well and were surprised to learn that sovereign Singapore fund invests 650B /year- Temasek. Yes, Enterprise Singapore and Singapore Innovation should be added to agenda along with Biotech and Tech incubator It was well organized event. In Asia, face to face meetings work better than digital, the event is a reminder of the value of in person interactions in Asia.